Haleon plc (NYSE:HLN) Short Interest Down 22.8% in October

Haleon plc (NYSE:HLN) saw a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 7,910,000 shares, a decline of 22.8% from the October 15th total of 10,240,000 shares. Based on an average daily trading volume, of 5,230,000 shares, the short-interest ratio is presently 1.5 days. Currently, 0.2% of the shares of the company are sold short.

Haleon Trading Up 0.9 %

Shares of Haleon stock opened at $9.39 on Friday. The business has a fifty day simple moving average of $10.10 and a 200-day simple moving average of $9.34. Haleon has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The firm has a market cap of $42.51 billion, a price-to-earnings ratio of 27.62, a price-to-earnings-growth ratio of 2.84 and a beta of 0.30. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44.

Institutional Investors Weigh In On Haleon

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Allspring Global Investments Holdings LLC bought a new position in shares of Haleon in the first quarter valued at $43,000. Sei Investments Co. raised its position in shares of Haleon by 79.1% during the first quarter. Sei Investments Co. now owns 781,089 shares of the company’s stock worth $6,632,000 after purchasing an additional 345,036 shares during the period. Russell Investments Group Ltd. lifted its holdings in shares of Haleon by 0.3% during the first quarter. Russell Investments Group Ltd. now owns 969,627 shares of the company’s stock valued at $8,232,000 after purchasing an additional 3,072 shares during the last quarter. Bleakley Financial Group LLC boosted its position in shares of Haleon by 32.4% in the 1st quarter. Bleakley Financial Group LLC now owns 16,174 shares of the company’s stock valued at $137,000 after purchasing an additional 3,956 shares during the period. Finally, Orion Portfolio Solutions LLC increased its stake in Haleon by 25.1% in the 1st quarter. Orion Portfolio Solutions LLC now owns 694,524 shares of the company’s stock worth $5,897,000 after purchasing an additional 139,263 shares in the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HLN has been the subject of a number of recent analyst reports. Berenberg Bank began coverage on Haleon in a report on Tuesday, August 6th. They issued a “buy” rating for the company. Morgan Stanley boosted their price target on Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a research report on Friday, September 20th. The Goldman Sachs Group lowered Haleon from a “buy” rating to a “neutral” rating in a report on Tuesday, August 6th. Finally, UBS Group raised shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Haleon has an average rating of “Buy” and a consensus price target of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.